Use of the Corus® CAD Gene Expression Test for Assessment of Obstructive Coronary Artery Disease Likelihood in Symptomatic Non-Diabetic Patients
Open Access
- 1 January 2013
- journal article
- Published by Public Library of Science (PLoS) in PLoS Currents
Abstract
The determination of the underlying etiology of symptoms suggestive of obstructive coronary artery disease (CAD, ≥50% stenosis in a major coronary artery) is a common clinical challenge in both primary care and cardiology clinics. Usual care in low to medium risk patients often involves a family history, risk factor assessment, and then stress testing with or without non-invasive imaging. If positive, this is often followed by invasive coronary angiography (ICA). Despite extensive adoption of this usual care paradigm, more than 60% of patients referred for angiography do not have obstructive CAD. In order to robustly identify those symptomatic patients without obstructive CAD, who can avoid subsequent cardiac testing and look elsewhere for the cause of their symptoms, a recently described whole blood gene expression score (GES: Corus® CAD, CardioDx, Inc., Palo Alto, CA) has been developed and validated in two multi-center trials. This paper reviews the published literature and assessments by independent parties regarding the analytical and clinical validity as well as the clinical utility of the Corus® CAD test.Keywords
This publication has 23 references indexed in Scilit:
- The Clinical Utility of Gene Expression Testing on the Diagnostic Evaluation of Patients Presenting to the Cardiologist With Symptoms of Suspected Obstructive Coronary Artery DiseaseCritical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 2013
- A Blood-Based Gene Expression Test for Obstructive Coronary Artery Disease Tested in Symptomatic Nondiabetic Patients Referred for Myocardial Perfusion Imaging The COMPASS StudyCirculation: Cardiovascular Genetics, 2013
- A gender-specific blood-based gene expression score for assessing obstructive coronary artery disease in nondiabetic patients: Results of the Personalized Risk Evaluation and Diagnosis in the Coronary Tree (PREDICT) TrialAmerican Heart Journal, 2012
- The Use of High-Throughput Technologies to Investigate Vascular Inflammation and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Multicenter Validation of the Diagnostic Accuracy of a Blood-Based Gene Expression Test for Assessing Obstructive Coronary Artery Disease in Nondiabetic PatientsAnnals of Internal Medicine, 2010
- The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working GroupGenetics in Medicine, 2009
- Summary of the American Heart Association’s Scientific Statement on the Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Approach to managing undiagnosed chest pain: could gastroesophageal reflux disease be the cause?2007
- Diagnosing the cause of chest pain.2005
- Chest pain and ischaemic heart disease in primary care.2003